SV Health Investors, LLC

13F Portfolio Filings

Latest 13F report
Q3 2022 - Nov 7, 2022
Value $
$32.3M
Signature - Title
Brent M. Faduski - Officer
Location
One Boston Place, 201 Washington Street, Suite 3900, Boston, MA
Holdings Value

List of Other Managers Reporting for SV Health Investors, LLC:

Name Holdings Value Location File Number
SV Life Sciences Fund VI (GP), L.P. Boston, MA 028-19255
SVLSF VI, LLC Boston, MA 028-19256
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2022 4 $32.3M BCYC, BVS, XFOR, ASXC 13F-HR 11/7/2022, 01:11 PM
Q2 2022 5 $43.8M -$5.53M -$5.53M AHCO, BCYC, BVS, XFOR, ASXC 13F-HR 8/12/2022, 04:19 PM
Q1 2022 5 $82.8M -$11.8M -$11.8M BCYC, BVS, AHCO, XFOR, ASXC 13F-HR 5/16/2022, 12:47 PM
Q4 2021 6 $155M +$22.9M -$31.5M -$8.64M BCYC, AHCO, STRO, BVS, XFOR 13F-HR 2/11/2022, 02:01 PM
Q3 2021 8 $204M +$4.2M -$42.5M -$38.3M BCYC, AHCO, MSON, STRO, DCPH 13F-HR 11/15/2021, 12:24 PM
Q2 2021 7 $230M $0 -$3.49M -$3.49M AHCO, BCYC, MSON, STRO, DCPH 13F-HR 8/16/2021, 04:26 PM
Q1 2021 8 $267M +$109M -$54.1M +$54.6M AHCO, BCYC, STRO, MSON, DCPH 13F-HR 5/17/2021, 07:00 AM
Q4 2020 8 $182M -$7.91M -$7.91M AMWL, STRO, BCYC, DCPH, MSON 13F-HR 2/16/2021, 03:18 PM
Q3 2020 10 $197M +$57.8M +$57.8M AMWL, BCYC, DCPH, KALV, MSON 13F-HR 11/12/2020, 03:26 PM
Q2 2020 10 $144M -$2.63M -$2.63M BCYC, DCPH, MSON, AVRO, KALV 13F-HR 8/14/2020, 06:31 AM
Q1 2020 10 $119M -$2.82M -$2.82M BCYC, AVRO, STRO, DCPH, MSON 13F-HR 5/15/2020, 06:05 AM
Q4 2019 10 $165M -$14.7M -$14.7M MSON, KALV, AVRO, DCPH, STRO 13F-HR 2/14/2020, 10:33 AM
Q3 2019 10 $142M +$34.1M -$20M +$14.1M MSON, BCYC, AVRO, KALV, DCPH 13F-HR 11/14/2019, 03:28 PM
Q2 2019 9 $149M +$19.3M -$9.69M +$9.57M KALV, AVRO, STRO, DCPH, BCYC 13F-HR 8/14/2019, 02:56 PM
Q1 2019 8 $170M +$7.69M -$39.4M -$31.7M KALV, AVRO, DCPH, STRO, TRXC 13F-HR 5/15/2019, 06:05 AM
Q4 2018 8 $162M -$21.2M -$21.2M KALV, AVRO, DCPH, STRO, TRXC 13F-HR 2/14/2019, 10:01 AM
Q3 2018 9 $342M +$27.4M -$8.9M +$18.5M AVRO, DCPH, KALV, TRXC, STRO 13F-HR 11/14/2018, 03:41 PM
Q2 2018 8 $218M +$78.5M -$2.43M +$76.1M AVRO, DCPH, TRXC, KALV, OCUL 13F-HR 8/6/2018, 12:03 PM
Q1 2018 7 $133M +$3.26M +$3.26M ASNS, DCPH, KALV, TRXC, OCUL 13F-HR 5/15/2018, 11:01 AM
Q4 2017 8 $189M +$27.2M +$27.2M ENTL, DCPH, KALV, ASNS, TRXC 13F-HR 2/14/2018, 10:24 AM
Q3 2017 7 $132M +$32.6M +$32.6M ENTL, DCPH, KALV, TRXC, OCUL 13F-HR 11/14/2017, 07:31 AM
Q2 2017 6 $92.9M ENTL, KALV, OCUL, TRXC, CATB 13F-HR 8/10/2017, 09:23 AM
Q1 2017 6 $90.5M -$7.36M -$7.36M ENTL, KALV, OCUL, TRXC, CATB 13F-HR 5/1/2017, 10:28 AM
Q4 2016 6 $119M +$18.2M -$2.74M +$15.5M ENTL, KALV, OCUL, CATB, TRXC 13F-HR 2/7/2017, 05:02 AM
Q3 2016 6 $130M +$186K +$186K ENTL, CATB, OCUL, TRXC, RPTP 13F-HR 11/14/2016, 07:16 AM
Q2 2016 6 $99M ENTL, CATB, OCUL, TRXC, RPTP 13F-HR 8/12/2016, 06:04 AM
Q1 2016 6 $134M ENTL, TRXC, OCUL, CATB, RPTP 13F-HR 5/13/2016, 07:49 AM
Q4 2015 6 $124M ENTL, CATB, TRXC, OCUL, RPTP 13F-HR 2/16/2016, 03:38 PM
Q3 2015 0 13F-HR 11/16/2015, 11:11 AM
Q2 2015 0 13F-HR 8/12/2015, 04:00 PM
Q1 2015 0 13F-HR 5/15/2015, 05:19 PM
Q4 2014 0 13F-HR 2/13/2015, 08:26 AM
Q3 2014 0 13F-HR 11/14/2014, 02:48 PM
Q2 2014 0 13F-HR 9/10/2014, 01:24 PM